Tanvex BioPharma, Inc. announced the appointment of James Williamson as Accounting Officer, effective February 6, 2024. James Williamson is VP of Finance of Tanvex BioPharma USA, Inc.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.55 TWD | +1.45% | +4.33% | -40.78% |
12:00am | Tanvex BioPharma, Inc.(TWSE:6541) dropped from S&P Global BMI Index | CI |
03-14 | Tanvex BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-40.78% | 196M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.11% | 22.1B | |
-8.75% | 18.34B | |
-41.70% | 16.59B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- 6541 Stock
- News Tanvex BioPharma, Inc.
- Tanvex BioPharma, Inc. Announces the Appointment of James Williamson as Accounting Officer